Literature DB >> 32504173

Baclofen pump with pre-brainstem catheter tip placement: technical note and case series.

Amparo Saenz1, Miguel Grijalba2, Juan Pablo Mengide2, Romina Argañaraz2, Fernando Ford3, Beatriz Mantese2.   

Abstract

PURPOSE: This study aims to describe a new baclofen pump implantation technique with pre-brainstem catheter placement and to demonstrate the benefits that this procedure has in treating spasticity and dystonia.
METHODS: We described a new technique to place a baclofen pump catheter anterior to the brainstem. To illustrate the technique, we presented five patients with both spasticity and dystonia in whom conventional treatment was not effective. They each received a baclofen pump with a pre-brainstem catheter. We evaluated the results using the Ashworth scale for spasticity, the Barry-Albright scale for dystonia, and the PedsQL for quality of life assessment. Each patient was evaluated before a surgery and after 6 months of follow-up.
RESULTS: There were statistically significant differences in all the physical examination evaluated areas using the Barry-Albright and modified Ashworth scales between the preoperative and the postoperative period. The same applies to the results of the PedsQL quality of life scale.
CONCLUSION: We presented an innovative baclofen pump implantation technique with pre-brainstem catheter placement that could be a therapeutic alternative in patients with dystonia and spastic quadriparesis for whom conventional therapy is not effective.

Entities:  

Keywords:  Baclofen; Baclofen pump; Cerebral palsy; Dystonia; Movement disorders; Spasticity

Mesh:

Substances:

Year:  2020        PMID: 32504173     DOI: 10.1007/s00381-020-04679-3

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.532


  24 in total

1.  PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS.

Authors:  B ASHWORTH
Journal:  Practitioner       Date:  1964-04

2.  Intrathecal baclofen therapy for spasticity of cerebral origin--does the position of the intrathecal catheter matter?

Authors:  Gnanamurthy Sivakumar; Yoong Yap; Mekidm Tsegaye; Michael Vloeberghs
Journal:  Childs Nerv Syst       Date:  2010-03-20       Impact factor: 1.475

Review 3.  Intrathecal baclofen bolus dosing and catheter tip placement in pediatric tone management.

Authors:  Andrew J Skalsky; Chrystal M Fournier
Journal:  Phys Med Rehabil Clin N Am       Date:  2015-02       Impact factor: 1.784

4.  Spasticity in children with cerebral palsy: what are we treating?

Authors:  Martin Gough
Journal:  Dev Med Child Neurol       Date:  2018-04-06       Impact factor: 5.449

5.  Reliability and responsiveness of the Barry-Albright Dystonia Scale.

Authors:  M J Barry; J M VanSwearingen; A L Albright
Journal:  Dev Med Child Neurol       Date:  1999-06       Impact factor: 5.449

6.  Infusion of intrathecal baclofen for generalized dystonia in cerebral palsy.

Authors:  A L Albright; M J Barry; M J Painter; B Shultz
Journal:  J Neurosurg       Date:  1998-01       Impact factor: 5.115

7.  [Spanish translation and validation of the Neuromuscular Module of the Pediatric Quality of Life Inventory (PedsQL): evaluation of the quality of life perceived by 8-18 years old children with neuromuscular diseases and by their parents].

Authors:  M Girabent-Farres; J Fagoaga; M Amor-Barbosa; C Bagur-Calafat
Journal:  Rev Neurol       Date:  2018-12-01       Impact factor: 0.870

8.  [Cerebral palsy: the concept and population-based registers].

Authors:  A Camacho-Salas; C R Pallás-Alonso; J de la Cruz-Bértolo; R Simón-de Las Heras; F Mateos-Beato
Journal:  Rev Neurol       Date:  2007 Oct 16-31       Impact factor: 0.870

9.  Intraventricular baclofen for dystonia: techniques and outcomes. Clinical article.

Authors:  A Leland Albright; Susan S Ferson
Journal:  J Neurosurg Pediatr       Date:  2009-01       Impact factor: 2.375

10.  Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study.

Authors:  J R Coffey; D Cahill; W Steers; T S Park; J Ordia; J Meythaler; R Herman; A G Shetter; R Levy; B Gill
Journal:  J Neurosurg       Date:  1993-02       Impact factor: 5.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.